Vasella forgoes golden handshake after furore
February 19, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Vasella
Novartis has backed down over plans to pay outgoing chairman Dr Daniel Vasella a ‘golden handshake’ worth $77 million (72 …
GSK plans greater use of biocatalysis, continuous processing
February 19, 2013Manufacturing and Production GSK, Witty, biocatalysis
GlaxoSmithKline says it is turning to technology to help improve the cost efficiency of its manufacturing operations, including greater use …
inVentiv Health names new European head
February 19, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentic Health
Michel Dubery has been named as the new managing director of inVentiv Health Communications in Europe. Dubery brings more than …
EU orphan designations rise
February 19, 2013Research and Development, Sales and Marketing COMP, EMA, Orphan, hta
The number of orphan drug designations in the EU is set to rise to record levels this year, according to …
New director at Havas PR
February 19, 2013Medical Communications Havas, Louise Stone, PR
Havas PR has brought in healthcare consultant Louise Stone to strengthen its health and wellness business. Louise takes on the role …
Genzyme’s Waterford plant gets new investment round
February 19, 2013Manufacturing and Production Genzyme, Sanofi, Waterford
Sanofi’s Genzyme unit plans to spend €44 million on upgrading its plant in Waterford, Ireland, to help meet demand for …
Gilead recalls Vistide on particle contamination
February 19, 2013Manufacturing and Production Gilead, Vistide
Gilead Sciences has issued a voluntary recall of one lot of its antiviral treatment Vistide after finding particulate matter in …
CMO plant shut down after Takeda product recall
February 19, 2013Manufacturing and Production CMP, OPG, Takeda
Japan’s regulatory authorities flexed their enforcement muscles last week when it ordered a temporary shutdown of the contract manufacturer for …
ViiV HIV drug boost
February 18, 2013Sales and Marketing Dolutegravir, GSK, HIV, ViiV
ViiV Healthcare has received a boost with the news that the FDA is to give a priority review to its …
Merck makes $688m payout
February 18, 2013Sales and Marketing ENHANCE, Inegy, Merck, Vytorin, investors
Merck has paid out $688 million to end two class-action lawsuits which sprang up after the revelation of disappointing trial …
Another approval for Novartis’ everolimus
February 18, 2013Sales and Marketing Certican, Novartis, Zortress, everolimus
Novartis has gained US approval for its drug Zortress (everolimus) to prevent liver transplant rejection.Zotress is already used to prevent …
Insulin blockbusters targeted by biosimilar blitz
February 15, 2013Research and Development, Sales and Marketing Biocon, Humalog, Mylan, insulin
Mylan and Biocon are the latest companies to announce major new plans to develop and market biosimilars. The firms are …
Janssen launches dementia prize
February 15, 2013Sales and Marketing Hunt, Janssen, NHS, dementia
Janssen has joined forces with the NHS to launch a scheme to financially reward solutions which can help the lives …
Fundraising to fuel e-Therapeutics’ ‘network pharmacology’
February 15, 2013Research and Development e-Therapeutics
Drug discovery and development firm e-Therapeutics hopes to raise £40 million via a new share offer to fund its research …
Lancet sparks agency row
February 15, 2013Medical Communications, Sales and Marketing ABPI, Lancet, Luther Pendragon, Marlboro, Phillip Morris
Communications agency Luther Pendragon has parted company with cigarette firm Philip Morris after attention was drawn to the agency’s other …
Nanobiotix appoints ex-Sanofi head Alain Herrera
February 14, 2013Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, nanobiotix
Nanomedicine firm Nanobiotix has announced that Dr Alain Herrera joins its Supervisory Board, succeeding Thierry Chopin and Isabelle Bou Antoun …
BMS hires Ann Powell Judge from Shire
February 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann Powell Judge, BMS, Shire
BMS has announced that Ann Powell Judge will join the company as senior vice president, Human Resources.From March Judge will …
Shire ADHD drug for UK
February 14, 2013Sales and Marketing ADHD, Shire, Vyvanse, elvanse
Shire’s attention-deficit hyperactivity disorder (ADHD) drug Elvanse has been given the go-ahead for use in the UK. Elvanse (lisdexamfetamine dimesylate), …
Delivering value in cost-constrained healthcare environments
February 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, MSI, NHS, VBP, austerity, value
As millions of pounds, euros and dollars are cut from healthcare budgets around the world – driven by austerity measures …
BMS in $438m OTC deal
February 14, 2013Sales and Marketing BMS, Reckitt Benckiser
Bristol-Myers Squibb has signed over the rights to sell, distribute and market half a dozen of its medicines, mainly sold …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
